Emergent BioSolutions Inc. Common Stock (EBS)

Emergent BioSolutions is a biotechnology company focused on developing and manufacturing high-quality medical countermeasures for infectious diseases, including vaccines and therapeutics

With an emphasis on public health, the company addresses a range of health threats, including those posed by bioterrorism, pandemic outbreaks, and antibiotic-resistant pathogens. Emergent works closely with government agencies and global health organizations to ensure preparedness against various health emergencies, leveraging advanced technologies and expertise in biopharmaceutical manufacturing to deliver effective solutions. Additionally, the company is involved in the production of specialty pharmaceutical products and provides contract development and manufacturing services to other organizations in the healthcare sector.